“The expansion of reimbursement treatment options primarily means more choices for patients and doctors in cases where previous treatment was not sufficiently effective or the disease has recurred. The changes are important for hundreds of patients suffering from ovarian and endometrial cancer,” Minister Linas Kukuraitis is quoted as saying in the statement.
Read more “Ryanair” reduces operations in Lithuania: two flight routes are discontinued
According to the ministry, maintenance treatment with rucaparib, which inhibits tumor growth, will be reimbursed for adult patients diagnosed with progressive high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer.
Read more Benjamin Netanyahu: diplomatic agreement with Iran’s «wild ones» is impossible
